RxDoctor Payments Data

Vanessa Raabe

Infectious Disease · New York, NYNPI 1356638555

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Merck accounts for 75.2% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for infectious disease clinicians in NY, where the typical reported total is $190.

$93in general payments, 2019–2025

Across 3 payments — averaging $31.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$70
  • VBI Vaccine (delaware) Inc.$23
$733,558in research payments, 2019–2025

Across 82 payments — averaging $8945.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$714K
  • Merck$15K
  • Pfizer$5K

What the payments were for

  • Food & beverage$93100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck2$70
VBI Vaccine (delaware) Inc.1$23

How this compares

$93 in reported general payments places this provider in the 35th percentile of 799 infectious disease providers in New York.

See all infectious disease providers in New York

Other infectious disease in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →